Leap Therapeutics, Inc. LPTX
Set alert
0.77 0.00 0.00%
As of Apr 1, 9:30 AM ET
0.7351 Day range 0.7971
1.68 52-week range 5.00
- YTD
- -73.28%
- 1 year
- -76.32%
- Open
- 0.7645
- Prev close
- 0.7696
- Mkt cap
- 110.74M
- Vol
- 848.47K
- Avg vol
- 360.35K
- EPS
- -1.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.7351
- High
- 0.7971
- Forward P/E
- -2.31
- Beta
- 0.22
- Short ratio
- 2.68
- Inst. own
- 40.30%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.07
- 200-d avg
- 2.66
- 1y target
- 11.38
2Y chart
Events in this range
- Mar 18, 2024Earnings: -0.46; estimate -0.56; surprise 17.86%
- Mar 19, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Mar 19, 2024Rating: Baird · Outperform → Outperform
- May 13, 2024Earnings: -0.51; estimate -0.57; surprise 10.53%
- May 14, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Jun 28, 2024Rating: Rodman & Renshaw · — → Buy
- Aug 12, 2024Earnings: -0.52; estimate -0.42; surprise -23.81%
- Aug 13, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 13, 2024Earnings: -0.44; estimate -0.46; surprise 4.35%
- Nov 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (122)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 12, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 12, 2025 | 11 months ago |
| RSI: Overbought | Nov 12, 2025 | 11 months ago |
| SMA: Bearish | Nov 11, 2025 | 11 months ago |
| SMA: Bullish | Nov 7, 2025 | 11 months ago |
| SMA: Bullish | Nov 7, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 29, 2025 | 1 year ago |
| SMA: Bullish | Oct 28, 2025 | 1 year ago |
| SMA: Bearish | Oct 16, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 16, 2025 | 1 year ago |
| SMA: Bullish | Oct 15, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bullish | Oct 8, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Oct 6, 2025 | 1 year ago |
| RSI: Overbought | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Oct 3, 2025 | 1 year ago |
| SMA: Bullish | Oct 2, 2025 | 1 year ago |
| RSI: Overbought | Sep 30, 2025 | 1 year ago |
| SMA: Bullish | Sep 25, 2025 | 1 year ago |
| SMA: Bearish | Sep 19, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| SMA: Bearish | Sep 17, 2025 | 1 year ago |
| SMA: Bullish | Sep 16, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 25, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 14, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 13, 2025 | 1 year ago |
| SMA: Bearish | Aug 5, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 31, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 24, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 9, 2025 | 1 year ago |
| RSI: Oversold | Jun 27, 2025 | 1 year ago |
| SMA: Bearish | Jun 20, 2025 | 1 year ago |
| SMA: Bullish | Jun 18, 2025 | 1 year ago |
| SMA: Bearish | Jun 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 4, 2025 | 1 year ago |
| SMA: Bullish | Jun 3, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 2, 2025 | 1 year ago |
| MACD: Buy Signal | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| SMA: Bearish | May 23, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 22, 2025 | 1 year ago |
| SMA: Bearish | May 21, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | May 12, 2025 | 1 year ago |
| MACD: Sell Signal | May 9, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 30, 2025 | 1 year ago |
| SMA: Bearish | Apr 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 25, 2025 | 1 year ago |
| RSI: Oversold | Apr 4, 2025 | 1 year ago |
| RSI: Oversold | Mar 27, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 13, 2025 | 1 year ago |
| RSI: Oversold | Jan 28, 2025 | 1 year ago |
| SMA: Bearish | Jan 16, 2025 | 1 year ago |
| SMA: Bearish | Jan 16, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 16, 2025 | 1 year ago |
| SMA: Bullish | Jan 13, 2025 | 1 year ago |
| SMA: Bearish | Jan 10, 2025 | 1 year ago |
| SMA: Bullish | Jan 2, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 2, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 19, 2024 | 1 year ago |
| SMA: Bearish | Dec 18, 2024 | 1 year ago |
| SMA: Bullish | Dec 17, 2024 | 1 year ago |
| SMA: Bearish | Dec 13, 2024 | 1 year ago |
| SMA: Bullish | Dec 4, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 4, 2024 | 1 year ago |
| SMA: Bearish | Dec 2, 2024 | 1 year ago |
| SMA: Bullish | Nov 27, 2024 | 1 year ago |
| SMA: Bearish | Nov 20, 2024 | 1 year ago |
| SMA: Bearish | Nov 14, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 7, 2024 | 1 year ago |
| RSI: Overbought | Oct 24, 2024 | 2 years ago |
| SMA: Bullish | Oct 18, 2024 | 2 years ago |
| SMA: Bullish | Oct 18, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 18, 2024 | 2 years ago |
| SMA: Bearish | Sep 23, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 6, 2024 | 2 years ago |
| RSI: Overbought | Aug 20, 2024 | 2 years ago |
| SMA: Bullish | Aug 8, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 8, 2024 | 2 years ago |
| SMA: Bearish | Aug 7, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 7, 2024 | 2 years ago |
| SMA: Bullish | Aug 6, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 6, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Jul 31, 2024 | 2 years ago |
| SMA: Bullish | Jul 30, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 26, 2024 | 2 years ago |
| SMA: Bearish | Jul 24, 2024 | 2 years ago |
| SMA: Bullish | Jul 23, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 3, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 2, 2024 | 2 years ago |
| RSI: Oversold | Jul 2, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 1, 2024 | 2 years ago |
| RSI: Oversold | Jun 18, 2024 | 2 years ago |
| RSI: Oversold | May 28, 2024 | 2 years ago |
| SMA: Bearish | May 16, 2024 | 2 years ago |
| SMA: Bullish | May 15, 2024 | 2 years ago |
| SMA: Bearish | May 14, 2024 | 2 years ago |
| SMA: Bullish | May 13, 2024 | 2 years ago |
| SMA: Bearish | May 10, 2024 | 2 years ago |
| MACD: Sell Signal | May 3, 2024 | 2 years ago |
| SMA: Bullish | Apr 9, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 21, 2024 | 2 years ago |
| RSI: Oversold | Mar 18, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 20, 2024 | 2 years ago |
| SMA: Bearish | Feb 15, 2024 | 2 years ago |
| SMA: Bullish | Feb 14, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 5, 2024 | 2 years ago |
| SMA: Bullish | Feb 1, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 9, 2024 | 2 years ago |
| RSI: Overbought | Jan 2, 2024 | 2 years ago |
| RSI: Overbought | Dec 22, 2023 | 2 years ago |
| RSI: Overbought | Dec 12, 2023 | 2 years ago |
Key statistics
- Market cap
- 110.74M
- Enterprise value
- 32.59M
- Trailing P/E
- 0.00
- Forward P/E
- -2.31
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.23
- EPS (TTM)
- -1.64
- Beta
- 0.22
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -30.07M
- Total cash
- 78.48M
- Total debt
- 482.00K
- Return on equity
- -80.54%
- Shares outstanding
- 38.32M
- Short % of float
- 3.13%
- 50-day average
- 3.07
- 200-day average
- 2.66
Analyst view
Consensus: none
Price target (mean) 11.38 +1378.0% upside
Now 0.7696
- Target (low)
- 5.50
- Target (mean)
- 11.38
- Target (high)
- 16.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy3
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.38333.
Financials — quick view
LPTX Revenue — quarterly 0
LPTX Net income — quarterly -3.30M
LPTX EPS — quarterly -0.08
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | -0.46 | -0.44 | +0.02 | +4.35% |
| Aug 12, 2024 | Jun 1, 2024 | -0.42 | -0.52 | -0.10 | -23.81% |
| May 13, 2024 | Mar 1, 2024 | -0.57 | -0.51 | +0.06 | +10.53% |
| Mar 18, 2024 | Dec 1, 2023 | -0.56 | -0.46 | +0.10 | +17.86% |
| Nov 13, 2023 | Sep 1, 2023 | -0.48 | -0.51 | -0.03 | -6.25% |
| Aug 14, 2023 | Jun 1, 2023 | -0.98 | -0.91 | +0.07 | +7.14% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jun 28, 2024 | Rodman & Renshaw | init | — | Buy |
| May 14, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Mar 19, 2024 | Baird | main | Outperform | Outperform |
| Mar 19, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
About Leap Therapeutics, Inc.
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candidates include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric and gynecologic cancers; and FL-301, a monoclonal antibody that targets cells that express Claudin18.2 on their cell surface and is in phase II clinical trial, as well as two preclinical antibody programs, FL-302 and FL-501. Leap Therapeutics, Inc. has an option and license agreement with NovaRock, Adimab, and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- leaptx.com
News
- Leap Therapeutics (NASDAQ:LPTX) vs. Panbela Therapeutics (OTCMKTS:PBLA) Head-To-Head Analysis
- Leap Therapeutics (NASDAQ:LPTX) and Nemus Bioscience (OTCMKTS:NMUS) Critical Contrast
- Contrasting Leap Therapeutics (NASDAQ:LPTX) and UCB (OTCMKTS:UCBJF)
- Reviewing Leap Therapeutics (NASDAQ:LPTX) and Vincerx Pharma (NASDAQ:VINC)
- Analyzing PaxMedica (NASDAQ:PXMD) and Leap Therapeutics (NASDAQ:LPTX)
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Dow Jumps More Than 400 Points; IHS Holding Posts Upbeat Q3 Results
- Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Your note
Sign in to keep a note on LPTX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAVANAUGH JAMES H | Director | Conversion of Exercise of derivative security | Nov 12, 2024 | 262,053 |
| LAWLOR AUGUSTINE | Chief Operating Officer | Conversion of Exercise of derivative security | Nov 12, 2024 | 0 |
| MIRABELLI CHRISTOPHER K | Chairman of the Board | Conversion of Exercise of derivative security | Nov 12, 2024 | 0 |
| O'MAHONY JOHN MARK | Officer | Conversion of Exercise of derivative security | Jan 25, 2024 | 5,000 |
| ONSI DOUGLAS E | Chief Executive Officer | Conversion of Exercise of derivative security | Nov 12, 2024 | 0 |
| SIRARD CYNTHIA M.D. | Officer | Conversion of Exercise of derivative security | Jan 25, 2024 | 5,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Balyasny Asset Management LLC | 8.05% | 3,085,104 | 8.92M | Sep 29, 2024 |
| Samsara BioCapital, LLC | 6.37% | 2,442,352 | 7.06M | Sep 29, 2024 |
| 683 Capital Management LLC | 3.60% | 1,380,500 | 3.99M | Sep 29, 2024 |
| Rock Springs Capital Management, LP | 3.31% | 1,266,546 | 3.66M | Sep 29, 2024 |
| Baker Bros. Advisors, LP | 3.06% | 1,172,175 | 3.39M | Sep 29, 2024 |
| Simplify Asset Management, Inc. | 2.76% | 1,056,895 | 3.05M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Simplify Exchange Traded Fds-Health Care ETF | 2.76% | 1,056,895 | 3.05M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 1.97% | 754,737 | 2.18M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.69% | 262,807 | 759.51K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.45% | 172,542 | 498.65K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.18% | 68,981 | 199.35K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.15% | 56,092 | 162.10K | Oct 30, 2024 |